5 Dumbest Things on...
Health Care: Drugs
Supernus Pharmaceuticals Inc (SUPN: NASDAQ)
$6.86 0.21 | 3.16%
05/24/13 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:2.44
Price Earnings Comparisons:
| SUPN | Sector Avg. | S&P 500 |
|---|---|---|
| 2.44 | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| -10.14 | 14.54 | 0.00 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 84.30 | -0.97 | -0.68 |
| Net Income | -100.00 | -101.57 | 0.00 |
| EPS | -100.00 | 0.00 | 0.00 |
Earnings for SUPN:
| EBITDA | -42.00 |
| REVENUE | 1.48M |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $-0.68 | $-0.74 | $-2.62 | $-1.32 |
| Number of Analysts | 2 | 2 | 3 | 2 |
| High Estimate | $-0.67 | $-0.67 | $-2.32 | $-1.27 |
| Low Estimate | $-0.68 | $-0.80 | $-2.97 | $-1.37 |
| Prior Year | $-0.61 | $-0.55 | $-2.72 | $-2.62 |
| Growth Rate (Year over Year) | -10.66% | -33.64% | 3.55% | 49.68% |
Portfolios with SUPN
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Rising On Unusual Vo...
- UserPharma
- ContributorStocks Under-$10 Moving Hig...
Latest SUPN Headlines from TheStreet
- 5 Stocks Under $10 Triggering Breakouts 03.21.13 | 01:03 pm
- Supernus Pharmaceuticals Reports Fourth Quarter 2012 And Full Year 2012 Financial Results 03.14.13 | 04:03 pm
- Supernus Announces Year-End And Fourth Quarter 2012 Earnings Conference Call And Webcast 03.07.13 | 09:03 pm
- Supernus Launches Oxtellar XR(TM) In The United States 02.01.13 | 08:02 am
- 5 Stocks Under $10 Poised to Pop 01.24.13 | 12:01 pm
- Supernus Appoints Victor Vaughn As Senior Vice President Of Sales 01.14.13 | 07:01 pm
- Hyperion Shares Poised to Run Up Ahead of FDA Decision 12.05.12 | 08:12 am
- Short Trade: Supernus IPO Lock-Up 10.31.12 | 07:10 am
- Supernus Receives FDA Approval For Oxtellar XR(TM) In Epilepsy 10.22.12 | 07:10 am
- 5 Stocks Poised for Breakouts 10.05.12 | 01:10 pm
Press Releases for SUPN
Partner Headlines for SUPN
- Supernus Secures Financing For CNS Pipeline Development - Seeking Alpha 05.05.13 | 07:05 am
- UPDATE: Citigroup Initiates Supernus Pharmaceuticals at Neutral; Fully Valued - Benzinga 11.27.12 | 01:11 pm
- Pipeline Advances at Supernus - Analyst Blog - Zacks 11.26.12 | 07:11 pm
- Apollo Group SPIKES 10% to Lead These 5 NASDAQ Top Percentage Winners - Wall St. Cheat Sheet 06.27.12 | 10:06 am
- SBA Enters MERGER Agreement and Other Stocks that Have Hit 52-Week Highs - Wall St. Cheat Sheet 06.27.12 | 10:06 am
- Morning Market Movers - Benzinga 06.26.12 | 09:06 am
